3 results match your criteria: "Onze-Lieve-Vrouw Clinic Aalst[Affiliation]"
Arrhythmia monitoring and outcome after myocardial infarction (BIO|GUARD-MI): a randomized trial.
Front Cardiovasc Med
May 2024
Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Objectives: Cardiac arrhythmias predict poor outcome after myocardial infarction (MI). We studied if arrhythmia monitoring with an insertable cardiac monitor (ICM) can improve treatment and outcome.
Design: BIO|GUARD-MI was a randomized, international open-label study with blinded outcome assessment.
A Bloody Pericardial Tap.
JACC Cardiovasc Interv
June 2023
Cardiovascular Center Aalst, Onze-Lieve-Vrouw Clinic Aalst, Aalst, Belgium. Electronic address: